Covered recipient · General Payments record
ENZO L ABAD
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation Pain Medicine
General Payments · PY2018–2024
$2,354.26
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $241.50 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $110.59 | 4 |
| Medtronic, Inc. | $41.72 | 2 |
| FORTE BIO-PHARMA LLC | $25.74 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $25.16 | 1 |
| IBSA Pharma Inc. | $23.73 | 1 |
| SPR Therapeutics, Inc | $14.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.94 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161196 | CMS |
| ABBVIE INC. | $30.86 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161198 | CMS |
| ABBVIE INC. | $26.74 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161200 | CMS |
| ABBVIE INC. | $24.05 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103161202 | CMS |
| Forte Bio-Pharma LLC | $25.74 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142415717 | CMS |
| IBSA Pharma Inc. | $23.73 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142985846 | CMS |
| Medtronic, Inc. | $18.41 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119558064 | CMS |
| Medtronic, Inc. | $23.31 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119558066 | CMS |
| SPR Therapeutics, Inc | $14.56 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104945878 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $25.16 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105916158 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.